drugset / Trial / NCT06137703
A Study to Learn About the Study Medication, Zavegepant, in Healthy Volunteers
RandomizedCrossoverOpen-labelBasic science
Summary
This trial is designed to compare the rate and extent of absorption of four different formulations of zavegepant. 52 healthy male and female volunteers will receive a single dose of each formulation at least 7 days apart over a period of about 7 weeks and the amount of drug in their blood will be assessed over the 24 hour period after each dose.
Timeline
- Start
- 2022-08-24
- Primary completion
- 2022-12-07
- Completion
- 2022-12-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zavegepant | Small molecule | 100 mg | — |
| Subject | Zavegepant | Small molecule | 200 mg | — |
Indications
No indication recorded.